Overall, the imminent role of NRAS mutations in melanoma aggressiveness and response to therapy has been well established, although much is still to discover about the impact of the remaining Ras family members in melanoma pathophysiology and as putative therapeutic targets. This evidence concerns the gene NRAS and melanoma.